Last edition
News about "Glenmark Pharma"
Glenmark Secures China's Approval For RYALTRIS
Glenmark Pharmaceuticals has received regulatory approval in China for RYALTRIS. Combining olopatadine hydrochloride and mometasone furoate, it offers dual-action relief from nasal symptoms, further strengthening Glenmark’s position as a global leader in respiratory innovation.
Glenmark Pharma | 11/11/2025 | By Dineshwori
With this new launch, the company aims to improve glycemic control in adult patients with uncontrolled type 2 diabetes
Glenmark Pharma | 21/10/2022 | By Sudeep Soparkar | 545
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy